Kemnay Advisory Services’s Soleno Therapeutics SLNO Stock Holding History

Kemnay Advisory Services’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-412	Closed	-$13.8K	–	1334
2026 Q1	$13.8K	Buy	+412	New	+$16.2K	﹤0.01%	889

Kemnay Advisory Services's SLNO Position: Q2 2026 in Review

Kemnay Advisory Services sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 412 shares — an estimated $13.8K sold.

Kemnay Advisory Services first reported a position in SLNO in Q1 2026 and held it in 1 quarter. The position peaked at $13.8K in Q1 2026. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

Kemnay Advisory Services reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
Kemnay Advisory Services sold 412 Soleno Therapeutics shares in Q2 2026, an estimated $13.8K.
Kemnay Advisory Services first reported a position in Soleno Therapeutics in Q1 2026 and held it in 1 quarter.
Kemnay Advisory Services's Soleno Therapeutics position peaked at $13.8K in Q1 2026.
0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on Kemnay Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.